First Tracks Biotherapeutics, Inc.

TRAX Nasdaq Healthcare · Pharmaceutical Preparations San Diego, CA www.firsttracksbio.com
$41.96
Mkt Cap 1.76B

Clinical-stage biotech developing treatments for autoimmune and inflammatory diseases; no approved products yet.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…